| Development of a potent brain-penetrant EGFR tyrosine kinase inhibitor against malignant brain tumors JE Tsang, LM Urner, G Kim, K Chow, L Baufeld, K Faull, TF Cloughesy, ... ACS Medicinal Chemistry Letters 11 (10), 1799-1809, 2020 | 23 | 2020 |
| Lipidomics in understanding pathophysiology and pharmacologic effects in inflammatory diseases: considerations for drug development K Ahluwalia, B Ebright, K Chow, P Dave, A Mead, R Poblete, SG Louie, ... Metabolites 12 (4), 333, 2022 | 18 | 2022 |
| Hyaluronic acid filler incidentally found during mohs micrographic surgery: observations in 36 patients regarding skin depth, degradation size, and estimated persistence time KV Chow, DS Urman, ES Cabral, EK Shim, RG Bennett Dermatologic Surgery 48 (4), 401-405, 2022 | 4 | 2022 |
| YouTube as a source of hidradenitis suppurativa patient education: a social media content analysis DP Raime, N Ezaldein, M Quiñones, K Chow, K Lukas, HH Ezaldein Cureus 15 (4), 2023 | 2 | 2023 |
| DDIS-08. DEVELOPMENT OF BRAIN-PENETRANT EGFR INHIBITORS FOR GLIOBLASTOMA J Tsang, L Urner, G Kim, K Chow, P Clark, T Cloughesy, M Jung, ... Neuro-Oncology 20 (Suppl 6), vi70, 2018 | | 2018 |
